T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.58B |
| 2 |
T-Mobile US
TMUS
|
+$1.53B |
| 3 |
Morgan Stanley
MS
|
+$1.15B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.15B |
| 5 |
Apple
AAPL
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$2.94B |
| 2 |
Amazon
AMZN
|
+$2.82B |
| 3 |
GE Aerospace
GE
|
+$1.93B |
| 4 |
Goldman Sachs
GS
|
+$1.88B |
| 5 |
ServiceNow
NOW
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.25% |
| 2 | Healthcare | 17.75% |
| 3 | Financials | 11.32% |
| 4 | Consumer Discretionary | 11.17% |
| 5 | Communication Services | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
AngioDynamics
ANGO
$647M
| $208K | ﹤0.01% |
20,108
-2,240
| -10% | -$28.7K |
|
2502
Buckle
BKE
$2.31B
| $208K | ﹤0.01% |
5,820
+537
| +10% | +$22K |
|
2503
Helix Energy Solutions
HLX
$1.49B
| $208K | ﹤0.01% |
26,850
+1,837
| +7% | +$14.4K |
|
2504
Customers Bancorp
CUBI
$2.82B
| $207K | ﹤0.01% |
11,142
+3,252
| +41% | +$88.7K |
|
2505
Phibro Animal Health
PAHC
$1.38B
| $207K | ﹤0.01% |
13,468
+504
| +4% | +$7.7K |
|
2506
Universal Electronics
UEIC
$66.6M
| $207K | ﹤0.01% |
20,379
+2,853
| +16% | +$49.7K |
|
2507
America Movil
AMX
$69.8B
| $205K | ﹤0.01% |
+9,700
| New | +$199K |
|
|
STRS
2508
DELISTED
STRATUS PPTYS INC
STRS
| $205K | ﹤0.01% |
10,203
+91
| +0.9% | +$1.89K |
|
2509
Axogen
AXGN
$2.58B
| $204K | ﹤0.01% |
21,584
-1
| -0% | -$9 |
|
|
DCH
2510
Dauch Corp
DCH
$1.6B
| $204K | ﹤0.01% |
26,082
+1,336
| +5% | +$11.5K |
|
2511
Microvast
MVST
$341M
| $204K | ﹤0.01% |
164,197
-15,125
| -8% | -$22K |
|
2512
Nektar Therapeutics
NKTR
$2.57B
| $203K | ﹤0.01% |
19,178
+1,986
| +12% | +$60.1K |
|
2513
Olema Pharmaceuticals
OLMA
$920M
| $203K | ﹤0.01% |
58,300
-10,200
| -15% | -$41.6K |
|
2514
VSE Corp
VSEC
$6.48B
| $203K | ﹤0.01% |
+4,501
| New | +$228K |
|
2515
First Internet Bancorp
INBK
$256M
| $202K | ﹤0.01% |
12,080
+3,500
| +41% | +$84.4K |
|
2516
National Bankshares
NKSH
$272M
| $202K | ﹤0.01% |
+6,400
| New | +$254K |
|
2517
Ocular Therapeutix
OCUL
$2.22B
| $202K | ﹤0.01% |
38,295
-3,566
| -9% | -$16.9K |
|
2518
Precigen
PGEN
$2.32B
| $202K | ﹤0.01% |
190,455
+11,721
| +7% | +$16.9K |
|
2519
Liquidity Services
LQDT
$1.35B
| $201K | ﹤0.01% |
15,257
+394
| +3% | +$5.36K |
|
2520
Xeris Biopharma Holdings
XERS
$1.52B
| $201K | ﹤0.01% |
122,979
| – | – |
|
2521
EVgo
EVGO
$519M
| $200K | ﹤0.01% |
25,614
+1,121
| +5% | +$6.59K |
|
|
DSKE
2522
DELISTED
Daseke, Inc. Common Stock
DSKE
| $200K | ﹤0.01% |
25,871
+719
| +3% | +$5.28K |
|
2523
Kodak
KODK
$978M
| $199K | ﹤0.01% |
48,352
+9,075
| +23% | +$32.8K |
|
|
MITT
2524
TPG Mortgage Investment Trust
MITT
$214M
| $199K | ﹤0.01% |
34,500
| – | – |
|
|
SLGC
2525
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $199K | ﹤0.01% |
77,923
+3,782
| +5% | +$10.8K |
|
Similar funds
T. Rowe Price Associates's Q1 2023 Portfolio in Review
As of Q1 2023, T. Rowe Price Associates held 3,020 positions worth $668B, up 7.5% from $622B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2023 filing shows 65 new, 1,711 increased, 924 reduced and 98 closed positions. Its largest new stake was Suncor Energy: 6,437,236 shares worth $200M. The largest sale was Alphabet (Google) Class C, an estimated $2.94B.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2023 buy was Suncor Energy: 6,437,236 shares worth $200M.
- T. Rowe Price Associates added most to Tesla in Q1 2023, an estimated $1.58B increase.
- T. Rowe Price Associates's biggest Q1 2023 reduction was Alphabet (Google) Class C, cutting an estimated $2.94B.
- T. Rowe Price Associates fully exited Signature Bank in Q1 2023, selling an estimated $360M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $668B portfolio in Q1 2023.
- T. Rowe Price Associates opened 65 new positions and closed 98 in Q1 2023.
- T. Rowe Price Associates's portfolio value rose 7.5% quarter-over-quarter to $668B.
Based on T. Rowe Price Associates's 13F filing for Q1 2023, filed 15 May 2023.